Providing long-term support for lifestyle changes: A key to success in diabetes prevention

Diabetes Spectrum

Volumn 20, Issue 4, 2007, Pages 205-209

  Marrero, David G ^a   Ackermann, Ronald T ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEHAVIOR CHANGE; BLOOD GLUCOSE MONITORING; CLINICAL TRIAL; DIABETES CONTROL; DIET RESTRICTION; DIETARY INTAKE; DISEASE COURSE; DISEASE PREDISPOSITION; HEALTH CARE COST; HEALTH PROGRAM; HEALTH SERVICE; HIGH RISK POPULATION; HUMAN; LIFESTYLE MODIFICATION; LONG TERM CARE; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSICAL ACTIVITY; REVIEW; RISK ASSESSMENT; RISK FACTOR; SELF CARE; SELF MONITORING; SMOKING HABIT; SYSTEMATIC REVIEW; WEIGHT REDUCTION;

EID: 36749033272     PISSN: 10409165     EISSN: None     Source Type: Journal    
DOI: 10.2337/diaspect.20.4.205     Document Type: Review

References (42)

1. Harris MI, Flegal KM, Cowie CC, Eberhart MS, Goldstein DE, Little RR, Wiedmeyer HM, Byrd-Holt DD: Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults: The Third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care 21:518-524, 1998
2. Mokdad AH, Bowman BA, Ford ES, Vinicor F, Marks JS, Koplan JP: The continuing epidemics of obesity and diabetes in the United States. JAMA 286:1195-1200, 2001
3. Centers for Disease Control and Prevention: Diabetes: Disabling, Deadly, and on the Rise. Atlanta, Ga., Centers for Disease Control and Prevention, Department of Health and Human Services, 2004
4. American Diabetes Association: National Diabetes Fact Sheet. Alexandria, Va., American Diabetes Association, 2002
5. Hogan P, Dall T, Nikolov P: Economic costs of diabetes in the U.S. in 2002. Diabetes Care 26:917-932, 2003
6. King H, Aubert RE, Herman WH: Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 21:1414-1431, 1998
7. Centers for Disease Control and Prevention: National Diabetes Fact Sheet: General Information and National Estimates on Diabetes in the United States, 2003. Atlanta, Ga., Centers for Disease Control and Prevention, Department of Health and Human Services, 2004
8. U.K. Prospective Diabetes Study Group: Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 352:854-865, 1998
9. U.K. Prospective Diabetes Study Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837-853, 1998
10. Knowler WC, Narayan KM, Hanson RL, Nelson RG, Bennett PH, Tuomilehto J, Schersten B, Pettitt DJ: Preventing non-insulin-dependent diabetes. Diabetes 44:483-488, 1995
11. Gillies CL, Abrams KR, Lambert PC, Cooper NJ, Suton AJ, Hsu RT, Khunti K: Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis. BMJ 334(7588):299, 2007
12. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM, Diabetes Prevention Program Research Group: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393-403, 2002
13. Burnet DL, Elliott LD, Quinn MT, Plaut AJ, Schwartz MA, Chin MH: Preventing diabetes in the clinical setting. J Gen Intern Med 21:84-93, 2006
14. Santaguida P, Balion C, Hunt D, Morrison K, Gerstein H, Raina P, Booker L, Yazdi H: Diagnosis, Prognosis, and Treatment of Impaired Glucose Tolerance and Impaired Fasting Glucose. Washington, D.C, Agency for Healthcare Research and Quality (Report No. 128), 2005
15. Hamman RF, Wing RR, Edelstein SL, Lachin JM, Bray GA, Delahanty L, Hoskin M, Kriska AM, Mayer-Davis EJ, Pi-Sunyer X, Regensteiner J, Venditti B, Wylie-Rosett J: Effect of weight loss with lifestyle intervention on risk of diabetes. Diabetes Care 29:2102-2107, 2006
16. Wing RR, Hamman RF, Bray GA, Delahanty L, Edelstein SL, Hill JO, Horton ES, Hoskin MA, Kriska A, Lachin J, Mayer-Davis EJ, Pi-Sunyer X, Regensteiner JG, Venditti B, Wylie-Rosett J; Diabetes Prevention Program Research Group: Achieving weight and activity goals among diabetes prevention program lifestyle participants. Obes Res 12:1426-1434, 2004
17. McTigue KM, Harris R, Hemphill B, Lux L, Sutton S, Bunton AJ, Lohr KN: Screening and interventions for obesity in adults: summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 139:933-949, 2003
18. Jeffery RW, Drewnowski A, Epstein LH, Stunkard AJ, Wilson GT, Wing RR, Hill DR: Long-term maintenance of weight loss: current status. Health Psychol 19 (Suppl. 1):5-16, 2000
19. Logue E, Sutton K, Jarjoura D, Smucker W, Baughman K, Capers C: Transtheoretical model-chronic disease care for obesity in primary care: a randomized trial. Obes Res 13:917-927, 2005
20. Hibbard JH, Mahoney ER, Stockard J, Tusler M: Development and testing of a short form of the patient activation measure. Health Serv Res 40:1918-1930, 2005
21. Hibbard JH, Stockard J, Mahoney ER, Tusler M: Development of the Patient Activation Measure (PAM): conceptualizing and measuring activation in patients and consumers. Health Serv Res 39:1005-1026, 2004
22. Walker EA, Caban A, Schechter CB, Basch CE, Blanco E, DeWitt T, Kalten MR, Mera MS, Mojica G: Measuring comparative risk perceptions in an urban minority population: the risk perception survey for diabetes. Diabetes Educ 33:103-110, 2007
23. Walker EA, Mertz CK, Kalten MR, Flynn J: Risk perception for developing diabetes: comparative risk judgments of physicians. Diabetes Care 26:2543-2548, 2003
24. The Diabetes Prevention Program Research Group: The Diabetes Prevention Program: baseline characteristics of the randomized cohort. Diabetes Care 23:1619-1629, 2000
25. Eden KB, Orleans CT, Mulrow CD, Pender NJ, Teutsch SM: Does counseling by clinicians improve physical activity? A summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 137:208-215, 2002
26. Pignone MP, Ammerman A, Fernandez L, Orleans CT, Pender N, Woolf S, Lohr KN, Sutton S: Counseling to promote a healthy diet in adults: a summary of the evidence for the U.S. Preventive Services Task Force. Am J Prev Med 24:75-92, 2003
27. Centers for Disease Control and Prevention: Physical Activity. Guide to Community Preventive Services. Atlanta, Ga., Centers for Disease Control and Prevention, 2006
28. Centers for Disease Control and Prevention: Tobacco: Guide to Community Preventive Services. Atlanta, Ga., Centers for Disease Control and Prevention, 2006
29. Obermayer JL, Riley WT, Asif O, Jean-Mary J: College smoking-cessation using cell phone text messaging. J Am Coll Health 53:71-78, 2004
30. Vidrine DJ, Arduino RC, Gritz ER: Impact of a cell phone intervention on mediating mechanisms of smoking cessation in individuals living with HIV/AIDS. Nicotine Tob Res 8 (Suppl. 1):S103-S108, 2006
31. Johnson FR, Manjunath R, Mansfield CA, Clayton LJ, Hoerger TJ, Zhang P: High-risk individuals' willingness to pay for diabetes risk-reduction programs. Diabetes Care 29:1351-1356, 2006
32. Ackermann RT, Marrero DG, Hicks KA, Hoerger TJ, Sorensen S, Zhang P, Engelgau MM, Ratner RE, Herman WH: An evaluation of cost sharing to finance a diet and physical activity intervention to prevent diabetes. Diabetes Care 29:1237-1241, 2006
33. Caro JJ, Getsios D, Caro I, Klittich WS, O'Brien JA: Economic evaluation of therapeutic interventions to prevent type 2 diabetes in Canada. Diabet Med 21:1229-1236, 2004
34. Herman WH, Hoerger TJ, Brandle M, Hicks K, Sorensen S, Zhang P, Hamman RF, Ackermann RT, Engelgau MM, Ratner RE; Diabetes Prevention Program Research Group: The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance. Ann Intern Med 142:323-332, 2005
35. Palmer AJ, Roze S, Valentine WJ, Spinas GA, Shaw JE, Zimmet PZ: Intensive lifestyle changes or metformin in patients with impaired glucose tolerance: modeling the long-term health economic implications of the diabetes prevention program in Australia, France, Germany, Switzerland, and the United Kingdom. Clin Ther 26:304-321, 2004
36. Herman WH, Brandle M, Zhang P, Williamson DF, Matulik MJ, Ratner RE, Lachin JM, Engelgau MM; Diabetes Prevention Program Research Group: Costs associated with the primary prevention of type 2 diabetes mellitus in the diabetes prevention program. Diabetes Care 26:36-47, 2003
37. Ackermann RT: Translating the DPP into the community: The YMCA model. Bethesda, Md., National Library of Medicine, National Institutes of Health Clinical Trials Registry, 2006. Available online from www.clinicaltrials.gov (Identifier NCT00302042)
38. Herman WH, Smith PJ, Thompson TJ, Engelgau MM, Aubert RE: A new and simple questionnaire to identify people at increased risk for undiagnosed diabetes. Diabetes Care 18:382-387, 1995
39. National Diabetes Education Program: Diabetes Prevention. Bethesda, Md., National Institutes of Health, the Centers for Disease Control and Prevention, Department of Health and Human Services, 2004
40. Rolka DB, Narayan KM, Thompson TJ, Goldman D, Lindenmayer J, Alich K, Bacall D, Benjamin EM, Lamb B, Stuart DO, Engelgau MM: Performance of recommended screening tests for undiagnosed diabetes and dysglycemia. Diabetes Care 24:1899-1903, 2001
41. Ackermann RT, Brizendine E, Zhou HH, Marrero DG: Translating the Diabetes Prevention Program into the community: The YMCA model. Presentation at the American Diabetes Association 67th Annual Meeting and Scientific Sessions, Chicago, 2007
42. Centers for Disease Control and Prevention: Obesity: Guide to Community Preventive Services. Atlanta, Ga., Centers for Disease Control and Prevention, 2006